Skip to main content

cancer Archives

Study finds patient messages help predict medication adherence

Jan. 31, 2019—Zhijun Yin and colleagues have found that breast cancer patients who message their doctors about certain topics are more likely to discontinue hormone therapy than others--which enables doctors to better predict which patients are at risk of stopping their treatment early.

Read more


Trans-institutional team documents potential new treatment path for breast cancer

Jan. 16, 2019—A team led by biomolecular engineer John Wilson and cancer biologist Rebecca Cook have found a way to trigger an immune response that targets breast cancer cells.

Read more


Study identifies novel genetic factors for colorectal cancer risk

Jan. 10, 2019—A large-scale study conducted among East Asians and led by Vanderbilt researchers has identified multiple, previously unknown genetic risk factors for colorectal cancer.

Read more


Breast cancer-killing RIG

Dec. 19, 2018—New research led by Rebecca Cook demonstrates that an antiviral receptor called RIG-I has potent immunogenic and therapeutic effects in breast cancer.

Read more


Philip’s liver cancer research receives V Foundation support

Dec. 13, 2018—The grant will support Mary Philip's research to develop an organoid model — a miniature cell model of a functioning organ — of the liver to enable three-dimensional observation of immune-cancer interactions at the single-cell level at the earliest stages of cancer development.

Read more


Lung cancer survival signal

Nov. 30, 2018—New research by Jonathan Lehman and Pierre Massion have identfied a bioimarker that suggests poor prognosis for small-cell lung cancer, as well as potential target for new therapies.

Read more


Vanderbilt study suggests way to prevent rare lung disease

Nov. 15, 2018—Pulmonary hypertension may be treated by targeting a bone marrow cell that normally promotes the growth of new blood vessels, according to new research by David Merryman.

Read more


Mary Kay Foundation grant to bolster immunotherapy research

Oct. 26, 2018—The grant will allow Charles Caskey to lead research into using ultrasound as an image-guided therapy for drug delivery.

Read more


Grant enhances study of new chemotherapy targets

Oct. 19, 2018—Vanderbilt chemists have been awarded $7.2 million over the next five years from the National Cancer Institute to lead an initiative to better understand how a combination chemotherapy for breast cancer targets DNA.

Read more


Team’s potential lung cancer therapy lands award from SBIR

Sep. 27, 2018—A potential cancer drug aimed at enhancing the effectiveness of ionizing radiation in lung cancer patients is a step closer to development with funding support from the Small Business Innovation Research program.

Read more


Cancer Moonshot award to help map tumor progression

Sep. 27, 2018—A trans-institutional team of researchers at Vanderbilt University Medical Center and Vanderbilt University has received an $11 million Cancer Moonshot grant to build a single-cell resolution atlas to map out the routes that benign colonic polyps take to progress to colorectal cancer, the third most common cancer among both men and women in the United States.

Read more


Limited submission opportunity: 2019 Rita Allen Foundation Scholars Award

Jun. 28, 2018—Vanderbilt (VU and VUMC collaboratively) may nominate one candidate for the Rita Allen Foundation Scholars Award Program for 2019. The foundation supports early-career biomedical scholars doing pioneering research. This award typically provides $550,000 over five yearsfor young investigators involved in research in the cure and treatment of diseases in the fields of cancer, immunology, and neuroscience.

Read more


Upcoming Events

MORE EVENTS »